Rottenstein Law Group Notes Report Suggesting Bone Density Retesting Can Be Postponed

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has read with keen interest a report suggesting that patients with normal bone density can delay retests. New York, NY (PRWEB) January 31, 2012 According to a piece that appeared recently in the New York Times, a new research study reports that “[b]one loss and osteoporosis develop so slowly in most women whose bones test normal at age 65 that many can safely wait as long as 15 years before having a second bone density test.” The study, which was published in the New
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations